Your browser doesn't support javascript.
loading
Technology-Enabled Clinical Trials: Transforming Medical Evidence Generation.
Marquis-Gravel, Guillaume; Roe, Matthew T; Turakhia, Mintu P; Boden, William; Temple, Robert; Sharma, Abhinav; Hirshberg, Boaz; Slater, Paul; Craft, Noah; Stockbridge, Norman; McDowell, Bryan; Waldstreicher, Joanne; Bourla, Ariel; Bansilal, Sameer; Wong, Jennifer L; Meunier, Claire; Kassahun, Helina; Coran, Philip; Bataille, Lauren; Patrick-Lake, Bray; Hirsch, Brad; Reites, John; Mehta, Rajesh; Muse, Evan D; Chandross, Karen J; Silverstein, Jonathan C; Silcox, Christina; Overhage, J Marc; Califf, Robert M; Peterson, Eric D.
Afiliación
  • Marquis-Gravel G; Duke Clinical Research Institute, Durham, NC (G.M.-G., M.T.R., B.P.-L., E.D.P.).
  • Roe MT; Duke Clinical Research Institute, Durham, NC (G.M.-G., M.T.R., B.P.-L., E.D.P.).
  • Turakhia MP; Center for Digital Health (M.P.T.), Stanford University, CA.
  • Boden W; VA Palo Alto Health Care System, CA (M.P.T.).
  • Temple R; Boston University and VA New England Health Care System, MA (W.B.).
  • Sharma A; U.S. Food and Drug Administration, Silver Spring, MD (R.T., N.S.).
  • Hirshberg B; Division of Cardiology (A.S.), Stanford University, CA.
  • Slater P; Division of Cardiology, McGill University Health Centre, Montreal, QC, Canada (A.S.).
  • Craft N; MedImmune, Gaithersburg, MD (B.H.).
  • Stockbridge N; Life Sciences Innovation, Microsoft, Seattle, WA (P.S.).
  • McDowell B; Science 37 Inc, Los Angeles, CA (N.C.).
  • Waldstreicher J; U.S. Food and Drug Administration, Silver Spring, MD (R.T., N.S.).
  • Bourla A; Novartis Pharma AG, Rotkreuz, Switzerland (B.M.).
  • Bansilal S; Johnson & Johnson, New Brunswick, NJ (J.W.).
  • Wong JL; Flatiron Health, New York (A.B.).
  • Meunier C; Bayer U.S. LLC Pharmaceuticals, Whippany, NJ (S.B.).
  • Kassahun H; AstraZeneca, Gaithersburg, MD (J.L.W.).
  • Coran P; Evidation Health, San Mateo, CA (C.M.).
  • Bataille L; Amgen Inc, Thousand Oaks, CA (H.K.).
  • Patrick-Lake B; Medidata, New York (P.C.).
  • Hirsch B; The Michael J. Fox Foundation for Parkinson's Research, New York (L.B.).
  • Reites J; Duke Clinical Research Institute, Durham, NC (G.M.-G., M.T.R., B.P.-L., E.D.P.).
  • Mehta R; SignalPath, Raleigh, NC (B.H.).
  • Muse ED; THREAD, Tustin, CA (J.R.).
  • Chandross KJ; Healthagen Outcomes, New York (R.M.).
  • Silverstein JC; Scripps Research Translational Institute; Division of Cardiovascular Disease, Scripps Clinic, Scripps Health, La Jolla, CA (E.D.M.).
  • Silcox C; Sanofi R&D, Bridgewater, NJ (K.J.C.).
  • Overhage JM; University of Pittsburgh, PA (J.C.S.).
  • Califf RM; Duke-Margolis Center for Health Policy, Washington, DC (C.S.).
  • Peterson ED; Cerner Corporation, Kansas City, MO (J.M.O.).
Circulation ; 140(17): 1426-1436, 2019 10 22.
Article en En | MEDLINE | ID: mdl-31634011
ABSTRACT
The complexity and costs associated with traditional randomized, controlled trials have increased exponentially over time, and now threaten to stifle the development of new drugs and devices. Nevertheless, the growing use of electronic health records, mobile applications, and wearable devices offers significant promise for transforming clinical trials, making them more pragmatic and efficient. However, many challenges must be overcome before these innovations can be implemented routinely in randomized, controlled trial operations. In October of 2018, a diverse stakeholder group convened in Washington, DC, to examine how electronic health record, mobile, and wearable technologies could be applied to clinical trials. The group specifically examined how these technologies might streamline the execution of clinical trial components, delineated innovative trial designs facilitated by technological developments, identified barriers to implementation, and determined the optimal frameworks needed for regulatory oversight. The group concluded that the application of novel technologies to clinical trials provided enormous potential, yet these changes needed to be iterative and facilitated by continuous learning and pilot studies.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Ensayos Clínicos como Asunto / Registros Electrónicos de Salud / Aplicaciones Móviles / Dispositivos Electrónicos Vestibles Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Circulation Año: 2019 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Ensayos Clínicos como Asunto / Registros Electrónicos de Salud / Aplicaciones Móviles / Dispositivos Electrónicos Vestibles Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Circulation Año: 2019 Tipo del documento: Article